Home › Conditions › Atrial Fibrillation — Fast Ventricular Rate
Cardiology
Atrial Fibrillation — Fast Ventricular Rate
In AF with rapid ventricular rate, first assess haemodynamic stability. Unstable (SBP <90, chest pain, syncope, acute pulmonary oedema) → DC cardioversion. Stable → rate control first. Always look for a precipitant.
AF Rate/Rhythm Control
The pathway
Assess haemodynamic status
- SBP <90, chest pain, syncope, or acute pulmonary oedema → UNSTABLE
- Immediate DC cardioversion: R-wave synchronised shock at maximum output. Call anaesthetics.
Stable: Rate control
- Bisoprolol 2.5–5mg PO or metoprolol 2.5mg IV slow bolus
- Or diltiazem if beta-blockers contraindicated; avoid in reduced-EF or acute decompensated heart failure
- Target HR <110 at rest.
Find the cause
- Infection/sepsis
- Electrolyte abnormalities (K+, Mg)
- Thyrotoxicosis
- PE
- MI
- Alcohol
Treat the underlying cause.
Anticoagulation decision
- CHA₂DS₂-VASc ≥2: offer anticoagulation after bleeding-risk assessment; men with score 1: consider it. Female sex alone: no indication
- If AF >48h: anticoagulate ≥3 weeks before rhythm control, or TOE-guided cardioversion with therapeutic peri-procedural anticoagulation if no thrombus.
Rhythm control
- Haemodynamically stable AF: consider pharmacological cardioversion (flecainide 300mg PO if no structural heart disease, or amiodarone IV).
- AF >24h or onset uncertain: ≥3 weeks therapeutic anticoagulation first, or TOE-guided cardioversion on therapeutic anticoagulation if no thrombus; cardiology-led plan.
Electrolytes
- Correct K+ (target >4 mmol/L)
- Mg (1–2g IV MgSO₄ if low).
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Bisoprolol | 2.5–5mg | PO | Rate control. Avoid in asthma, decompensated HF. |
| Metoprolol | 2.5mg | IV | Slow bolus. Can repeat. Rate control in acute setting. |
| Digoxin | 500mcg | IV | Rate control if beta-blockers contraindicated (e.g. severe HF). Slow onset. |
| Amiodarone | 300mg over 1h then 900mg over 23h | IV | Rhythm control. Use in structural heart disease. |
| Flecainide | 300mg | PO | Rhythm control. ONLY if no structural heart disease or coronary disease. |
| Apixaban | 5mg BD | PO | Anticoagulation. Reduce to 2.5mg BD if 2/3 criteria: age≥80, weight≤60kg, Cr≥133. |
When to escalate
- Haemodynamic instability → immediate DC cardioversion
- Suspected WPW (irregular broad complex) → do not use AV nodal blockers
- Refractory rate despite dual rate control agents
- New onset in ACS or post-cardiac surgery
Reference: ESC AF Guidelines 2024 / NICE NG196 / RCUK tachyarrhythmia algorithm March 2026
Practise and explore
Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.